The NYU Langone health system has announced that NYU Winthrop Hospital in Mineola will change its name to NYU Langone Hospital-Long Island, pending approval from the New York State Department of Health.
The newly rechristened institution was originally known as Nassau Hospital upon its founding in 1896, later incorporating Winthrop into its name. The hospital was merged into the NYU Langone system in August 2019.
“NYU Langone Hospital-Long Island has made our NYU Langone Health system even stronger, as we bring its greatest strengths into our broader network,” said Dr. Robert I. Grossman, dean and CEO of NYU Langone Health. “NYU Langone Health provides one standard of care – excellence in quality and safety – no matter where that care is received within our health system.”
NYU Langone Hospital-Long Island credits its affiliation with NYU Langone Health for helping it achieve one of the lowest COVID-19 mortality rates in New York state during the initial surge when Long Island was labeled a “hot spot” for the infection. During that time, NYU Langone Hospital-Long Island accessed lifesaving extracorporeal membrane oxygenation (ECMO) heart-lung machines through its collaboration with NYU Langone. It is among many expanded clinical services the Long Island hospital now offers as part of NYU Langone Health.
“NYU Langone Hospital-Long Island has grown from a community-based hospital to one with a much broader mission, having solidified our ties in clinical, research and academic collaborations with NYU Langone Health,” said Dr. Joseph Greco, chief of hospital operations at NYU Langone Hospital-Long Island. “As advances in medical care grow by leaps and bounds, it has become ever the more important that our institution becomes synonymous with an extensive network of health care choices.”
In addition to that joint initiative during the COVID pandemic, which is part of an advanced heart failure program, NYU Langone Hospital-Long Island’s further enhancements in collaboration with NYU Langone Health include access to expanded clinical trials, including for cancer through Perlmutter Cancer Center; lifesaving transplant services, such as for kidney, pancreas, liver and heart transplants, an expansion of neurosurgery services, including a newly opened, integrated orthopedic and neurosurgery ambulatory center in East Meadow; a new NYU Langone Health Vaccine Center testing site on Long Island, aimed at breakthroughs in areas such as COVID-19; a renewed commitment to academic excellence with the opening last year of NYU Long Island School of Medicine, which brought to the campus of NYU Langone Hospital-Long Island the teaching excellence of one of the nation’s best medical schools; and a strengthened research enterprise on Long Island.
